Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer

Por Derosa, L, Hellmann, M D, Spaziano, M, Halpenny, D, Fidelle, M, Rizvi, H, Long, N, Plodkowski, A J, Arbour, K C, Chaft, J E, Rouche, J A, Zitvogel, L, Zalcman, G, Albiges, L, Escudier, B, Routy, B
Publicado no Ann Oncol (2018)

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Por Sabari, J K, Leonardi, G C, Shu, C A, Umeton, R, Montecalvo, J, Ni, A, Chen, R, Dienstag, J, Mrad, C, Bergagnini, I, Lai, W V, Offin, M, Arbour, K C, Plodkowski, A J, Halpenny, D F, Paik, P K, Li, B T, Riely, G J, Kris, M G, Rudin, C M, Sholl, L M, Nishino, M, Hellmann, M D, Rekhtman, N, Awad, M M, Drilon, A
Publicado no Ann Oncol (2018)